Margaret A. Hamburg, M.D.
Former Commissioner of the U.S. Food and Drug Administration
Margaret A. Hamburg, MD, Joins NTI as Interim Vice President for NTI | bio
NTI board member Margaret A. Hamburg, MD, is joining NTI’s leadership to serve as interim vice president of the NTI | bio program in February. Hamburg, an internationally recognized leader in public health and medicine, replaces Beth Cameron, PhD, who has moved to the White House to rebuild the National Security Council’s Office of Global Health Security and Biodefense and advance the Biden Administration’s agenda on global health security.
Hamburg’s relationship with NTI goes back to its launch in 2001, when she was named as the organization’s founding senior scientist and biological program vice president. She went on to become commissioner of the Food and Drug Administration and foreign secretary of the National Academy of Medicine.
Hamburg joined NTI’s Board of Directors in 2017.
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
More News
NTI Resources on the War in Ukraine
As the war in Ukraine continues, destroying cities and causing the worst humanitarian crisis in Europe in a generation, NTI’s policy experts are fanning out across the news media to discuss the implications of Putin’s actions
Global Biosecurity Dialogue Convenes in Cape Town to Improve Biosecurity and Address Emerging Risks
NTI | bio convened experts from around the world from governments, industry, and civil society in Cape Town, South Africa to discuss emerging biological risks and offer actions to address them.
NTI Expert Angela Kane Discusses Global Biosecurity Gaps at SOAS Director’s Lecture
NTI Senior Advisor Angela Kane joined a prestigious lecture series to discuss steps we can take to prepare for the next biological event on the scale of COVID-19.
